Contrast-enhanced MRI reliably predicts whether acute stroke patients receiving intravenous tPA treatment are particularly susceptible to intracranial hemorrhage, according to a study presented at the American Society of Neuroradiology meeting in San Diego.
Contrast-enhanced MRI reliably predicts whether acute stroke patients receiving intravenous tPA treatment are particularly susceptible to intracranial hemorrhage, according to a study presented at the American Society of Neuroradiology meeting in San Diego.
Dr. David J. Mikulis, an associate professor of neuroradiology at Toronto Western Hospital, reported that the presence of blood-brain barrier breakdown identified with postgadolinium T1-weighted spin-echo imaging produced 100% positive and negative predictive values for 10 of 24 patients who developed hemorrhagic transformation.
Hyperintensities were absent in all 14 patients without intracranial bleeding but were seen in five of 10 patients who developed hemorrhage in the week following treatment.
Studies presented by Mikulis and other researchers at the meeting added weight to growing evidence demonstrating the power of MRI and CT to determine when tPA thrombolysis should be attempted beyond the traditional three-hour treatment window.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.